Hanall Biopharma Co., Ltd.

009420.KS · Moat type: REGULIERUNG

MoatScore

2/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

Hanall Biopharma is a South Korean pharmaceutical company that develops, manufactures, and markets specialty and generic pharmaceuticals in the fields of ophthalmology, dermatology, cardiology, and oncology.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.